The Oncology Institute, Inc. (TOI) Q1 2024 Annual Earnings
TOI·Reported May 14, 2024·After market close
The Oncology Institute, Inc. reported Q1 2024 revenue of $94.7M, missed analyst consensus of $95.2M by $494.0K. Diluted EPS came in at $-0.22, missed the $-0.12 consensus by $0.10.
Revenue
$94.7Mmissed by $494.0K
Consensus: $95.2MDiluted EPS
$-0.22missed by $0.10
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about The Oncology Institute, Inc.'s Q1 2024 earnings report.
The Oncology Institute, Inc. (TOI) reported Q1 2024 earnings on May 14, 2024 after market close.
The Oncology Institute, Inc. reported revenue of $94.7M and diluted EPS of $-0.22 for Q1 2024.
Revenue missed the consensus estimate of $95.2M by $494.0K. EPS missed the consensus estimate of $-0.12 by $0.10.
You can read the 10-K/A periodic report (0001079973-24-000580) directly on SEC EDGAR. The filing index links above go to sec.gov.